Analyst Issues ‘Buy’ Rating on Ascendis Pharma, Anticipates FDA Approval for TransCon PTH
TipRanks (Thu, 16-May 4:13 AM ET)
Ascendis Pharma (ASND) Gets a Hold from Oppenheimer
TipRanks (Wed, 15-May 7:46 AM ET)
Analysts Are Bullish on These Healthcare Stocks: Ascendis Pharma (ASND), Sanara MedTech (SMTI)
TipRanks (Wed, 15-May 7:20 AM ET)
Ascendis Pharma (ASND) Receives a Hold from TD Cowen
TipRanks (Wed, 15-May 7:15 AM ET)
TipRanks (Wed, 15-May 6:40 AM ET)
Positive Outlook on Ascendis Pharma with Buy Rating Amid Expected US Approval of TransCon PTH
TipRanks (Wed, 15-May 5:57 AM ET)
TipRanks (Tue, 14-May 9:10 PM ET)
Optimistic Outlook for Ascendis Pharma Despite FDA Delay: A Strong Buy Recommendation
TipRanks (Tue, 14-May 4:55 PM ET)
FDA Delays Ascendis Pharma’s Drug Review
TipRanks (Tue, 14-May 3:58 PM ET)
Ascendis Pharma says FDA has delayed TransCon PTH review
Seeking Alpha News (Tue, 14-May 3:08 PM ET)
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates in North America, China, and Europe and derives the majority of its revenue from North America.
Ascendis Pharma A/S - American Depositary Shares trades on the NASDAQ stock market under the symbol ASND.
As of May 16, 2024, ASND stock price climbed to $124.28 with 69,238 million shares trading.
ASND has a beta of 0.85, meaning it tends to be less sensitive to market movements. ASND has a correlation of 0.11 to the broad based SPY ETF.
ASND has a market cap of $7.03 billion. This is considered a Mid Cap stock.
In the last 3 years, ASND stock traded as high as $178.71 and as low as $61.58.
The top ETF exchange traded funds that ASND belongs to (by Net Assets): IBB, CGGR, SPDW, FDG, MEDI.
ASND has underperformed the market in the last year with a price return of +28.7% while the SPY ETF gained +30.0%. ASND has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -15.6% and -11.9%, respectively, while the SPY returned +5.9% and +6.0%, respectively.
ASND support price is $120.79 and resistance is $127.29 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ASND stock will trade within this expected range on the day.